Credent Connect N Care IPO Listing Details
| Listing Date | August 20, 2026 |
| NSE Code | CREDENT |
| ISIN Code | INE1KPX01025 |
| Offer Price | ā¹179 to ā¹189 |
| Face Value | ā¹10 |
| Listing Price | ā¹359.10 |
Details about the Credent Connect N Care IPO
Credent Connect N Care has received approval from SEBI for an IPO of ā¹93.90 crores, via a fresh issue with a face value of ā¹10 each. Moreover, the company has set up a price band between ā¹179 to ā¹189 per share.
In this IPO, a total of 1200 shares were available in 2 lot sizes for the minimum Retail category and maximum Retail category.
- S-HNI (Min) has a total of 1800 shares in 3 lot sizes.
- SHNI (Max) has 4800 shares in 8 lot sizes.
- B-HNI Minimum: 5400 shares in 9 lot sizes.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum & Maximum investment of ā¹2,26,800.
- S-HNI (Minimum): Minimum investment of ā¹3,40,200.
- S-HNI Maximum: Investment of ā¹9,07,200.
- B-HNI Minimum: Investment of ā¹10,20,600.
Subscription duration of the Credent Connect N Care IPO
The opening date of the Credent Connect N Care IPO subscription was August 13, 2026, and the closing date was August 17, 2026. The Credent Connect N Care IPO allotment was finalised on August 18, 2026, and the IPO listing is on August 20, 2026.
Funds Deployment of This Company
- Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement
- To meet Working Capital Requirements
- Repayment and/or repayment, in full or part, of borrowing availed by the Company
- General corporate purposes
About the Credent Connect N Care IPO
Credent Connect N Care Limited, founded in 2015, is one of the leading transport and logistics companies in India. The firm is involved in offering logistics, cold chain solutions, warehousing, and supply chain services for the logistics, cold chain solutions, and warehousing sectors.
The firm offers B2B Healthcare Logistics Services such as transportation of diagnostic samples and services to IVD companies for reagent movement from their C&F to labs. C3 has over 12 years of experience across 452 cities and employs 6,500+ healthcare personnel.
